Table 4.
Target gene | Primer sequence | Amplicon length (BP) | GenBank accession |
---|---|---|---|
MMP‐2 | Forward: 5′‐GGAGATCTTCTTCTTCAAGGACCG‐3′ | 89 | AF177217 |
Reverse: 5′‐AGAATGTGGCTACCAGCAGGG‐3′ | |||
MMP‐9 | Forward: 5′‐CATGACATCTTCCAGTACCAAG‐3′ | 85 | AB006421 |
Reverse: 5′‐GGTTCACCTCATTCCGAGAA‐3′ | |||
Probe: 5′‐FAMCTACTTCTGCCAGGACCGCTTCTACTTAMRA‐3′ | |||
HPRT | Forward: 5′‐GAGATGACCTCTCAACTTTAACTGAAAA‐3′ | 89 | CFU16661 |
Reverse: 5′‐GGGAAGCAAGGTTTGCATTG‐3′ | |||
EF‐1α | Forward: 5′‐CAAAAACGACCCACCAATGG‐3′ | 68 | AY195837 |
Reverse: 5′‐GGCCTGGATGGTTCAGGATA‐3′ | |||
GAPDH | Forward: 5′‐GTCATCAACGGGAAGTCCATCTC‐3′ | 84 | AB038240 |
Reverse: 5′‐AACATACTCAGCACCAGCATCAC‐3′ |
BP = base pairs; EF‐1α = elongation factor 1α; GAPDH = glyceraldehyde‐3‐phosphate‐dehydrogenase; HPRT = hypoxanthine‐guanine phosphoribosyltransferase; MMP = matrix metalloproteinase.